4'-O-coumaroyl-isovitexine

structure in first source

Also Known As:

vitalboside

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        4'-O-coumaroyl-isovitexine: 2
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        4'-O-coumaroyl-isovitexine: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        4'-O-coumaroyl-isovitexine: 2
      - Chromones: 159
        Flavonoids: 9773
        Isoflavones: 2663
        4'-O-coumaroyl-isovitexine: 2

Experts

1.	Lakshmi, Baddireddi Subhadra: 1 article (01/2016)
2.	Muthukumaran, Padmanaban: 1 article (01/2016)
3.	Muthusamy, Velusamy Shanmuganathan: 1 article (01/2016)
4.	Sarath Kumar, Baskaran: 1 article (01/2016)
5.	Thiyagarajan, Gopal: 1 article (01/2016)
6.	Küpeli, Esra: 1 article (04/2007)
7.	Yesilada, Erdem: 1 article (04/2007)

Related Diseases

1.	Obesity 01/01/2016 - "Vitalboside A is a bifunctional molecule derived from edible plant showing inhibition of PTP1B and partial agonism to peroxisome proliferator-activated receptor γ which could be a promising therapeutic agent in the management of obesity and diabetes."
2.	Insulin Resistance 01/01/2016 - "Selective Inhibition of PTP1B by Vitalboside A from Syzygium cumini Enhances Insulin Sensitivity and Attenuates Lipid Accumulation Via Partial Agonism to PPARγ: In Vitro and In Silico Investigation."
3.	Inflammation (Inflammations) 04/04/2007 - "Vitalboside showed a potent and dose-dependent (in 75 and 150 mg/kg does, per os) in vivo anti-inflammatory activity against acute (carrageenan-, serotonin- and PGE(2)-induced hind paw edema model, castor oil-induced diarrhea), subacute (subcutaneous air-pouch) and chronic (Freund's complete adjuvant-induced arthritis) models of inflammation. "
4.	Edema (Dropsy) 04/04/2007 - "Vitalboside showed a potent and dose-dependent (in 75 and 150 mg/kg does, per os) in vivo anti-inflammatory activity against acute (carrageenan-, serotonin- and PGE(2)-induced hind paw edema model, castor oil-induced diarrhea), subacute (subcutaneous air-pouch) and chronic (Freund's complete adjuvant-induced arthritis) models of inflammation. "
5.	Diarrhea 04/04/2007 - "Vitalboside showed a potent and dose-dependent (in 75 and 150 mg/kg does, per os) in vivo anti-inflammatory activity against acute (carrageenan-, serotonin- and PGE(2)-induced hind paw edema model, castor oil-induced diarrhea), subacute (subcutaneous air-pouch) and chronic (Freund's complete adjuvant-induced arthritis) models of inflammation. "

Related Drugs and Biologics

1.	Peroxisome Proliferator-Activated Receptors (PPAR)
2.	Serotonin (5 Hydroxytryptamine)
3.	Prostaglandins E
4.	Lipids
5.	Castor Oil (Oil, Castor)
6.	Carrageenan